{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:53:48Z","timestamp":1782489228397,"version":"3.54.5"},"reference-count":112,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"unspecified","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009898","name":"Beckett-Fonden","doi-asserted-by":"publisher","award":["24-2-12380"],"award-info":[{"award-number":["24-2-12380"]}],"id":[{"id":"10.13039\/501100009898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["10.46540\/2096-00007B"],"award-info":[{"award-number":["10.46540\/2096-00007B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008269","name":"L\u00e6ge Sofus Carl Emil Friis og Hustru Olga Doris Friis\u2019 Legat","doi-asserted-by":"publisher","award":["1364542"],"award-info":[{"award-number":["1364542"]}],"id":[{"id":"10.13039\/501100008269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006197","name":"Fonden til L\u00e6gevidenskabens Fremme","doi-asserted-by":"publisher","award":["2024-01093"],"award-info":[{"award-number":["2024-01093"]}],"id":[{"id":"10.13039\/501100006197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010306","name":"Direkt\u00f8r Kurt B\u00f8nnelycke og Hustru fru Grethe B\u00f8nnelyckes Fond","doi-asserted-by":"publisher","award":["J.nr.: 24-B2-0052"],"award-info":[{"award-number":["J.nr.: 24-B2-0052"]}],"id":[{"id":"10.13039\/501100010306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003035","name":"Aase og Ejnar Danielsens Fond","doi-asserted-by":"publisher","award":["24-10-0615"],"award-info":[{"award-number":["24-10-0615"]}],"id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007403","name":"Dagmar Marshalls Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007403","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,4,16]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Bipolar II disorder (BDII) accounts for the majority of patients with bipolar disorder (BD), yet evidence supporting first-line mood stabilising treatment with lithium and lamotrigine is scarce, and the certainty of the evidence is very low. This highlights a critical evidence gap within psychiatric care. The lithium versus lamotrigine-bipolar randomised controlled trial (RCT) aims to compare lithium and lamotrigine on self-rated day-to-day mood instability (MI) and other patient-centred outcomes in BDII, hypothesising the superiority of lithium.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>A two-arm, single-blind, parallel-group, superiority RCT with a target sample size of 200 patients (accounting for attrition), recruiting patients with newly diagnosed BDII from specialised outpatient mood disorder clinics in the capital region of Copenhagen, Denmark. Participants are randomised in a 1:1 ratio to receive either lithium or lamotrigine for 6\u2009months. The primary outcome is MI, assessed via daily smartphone-based mood ratings. MI is chosen as the primary outcome measure due to its internal validity as a real-life measure for patients and external validity as it reflects both illness severity and functional impairment. Secondary outcomes include the proportion of participants showing a non-response to treatment and observer-rated changes in depressive symptoms over 6\u2009months, measured using the six-item version of the Hamilton Depression Rating Scale. Primary analyses will follow the intention-to-treat principle using linear mixed models. The trial is monitored by the good clinical practice.<\/jats:p>\n                    <jats:p>Recruitment commenced on 8 May 2024, and the final participant follow-up (last patient last visit) is expected on 1 December 2027.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The trial has received approvals from the Danish Research Ethics Committee, the Danish Medicines Agency (EU CT No. 2023\u20135\u200909\u2009607-32-00) and the Capital Region Data Agency (P-2023-307). Results will be published in peer-reviewed journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      Clinicaltrials.gov\/\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT06184581\">NCT06184581<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-116196","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:05:54Z","timestamp":1778249154000},"page":"e116196","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Lithium versus lamotrigine in bipolar disorder type II: protocol for a single-blinded, pragmatic, randomised controlled trial (the LiLa-Bipolar RCT)"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct06184581","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4653-3278","authenticated-orcid":false,"given":"Mette Ungermann","family":"Fredskild","sequence":"first","affiliation":[{"name":"Copenhagen Affective Disorder Research Centre (CADIC), Copenhagen University Hospital, Mental Health Services CPH, Psychiatric Center Copenhagen, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9401-358X","authenticated-orcid":false,"given":"Caroline Fussing","family":"Fussing Bruun","sequence":"additional","affiliation":[{"name":"Copenhagen Affective Disorder Research Centre (CADIC), Copenhagen University Hospital, Mental Health Services CPH, Psychiatric Center Copenhagen, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamilla Woznica","family":"Miskowiak","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"},{"name":"Neurocognition and Emotion Across Disorders of the Brain Center (NEAD), Copenhagen University Hospital, Mental Health Services CPH, Psychiatric Center Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esben","family":"Budtz-J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maj","family":"Vinberg","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"},{"name":"The Early Multimodular Prevention and Intervention Research Institution (EMPIRI) Mental Health Centre, Northern Zealand, Copenhagen University Hospital - Mental Health Services CPH, Hiller\u00f8d, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0462-6444","authenticated-orcid":false,"given":"Maria","family":"Faurholt-Jepsen","sequence":"additional","affiliation":[{"name":"Copenhagen Affective Disorder Research Centre (CADIC), Copenhagen University Hospital, Mental Health Services CPH, Psychiatric Center Copenhagen, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9377-9436","authenticated-orcid":false,"given":"Lars Vedel","family":"Kessing","sequence":"additional","affiliation":[{"name":"Copenhagen Affective Disorder Research Centre (CADIC), Copenhagen University Hospital, Mental Health Services CPH, Psychiatric Center Copenhagen, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"2026062608320578000_16.5.e116196.1","doi-asserted-by":"crossref","first-page":"18008","DOI":"10.1038\/nrdp.2018.8","article-title":"Bipolar disorders","volume":"4","author":"Vieta","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2026062608320578000_16.5.e116196.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61611-6"},{"key":"2026062608320578000_16.5.e116196.3","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12296"},{"key":"2026062608320578000_16.5.e116196.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2015.03.027"},{"key":"2026062608320578000_16.5.e116196.5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.bbi.2024.03.029","article-title":"A composite immune and vascular stress marker in patients newly diagnosed with bipolar disorder and their unaffected first-degree relatives","volume":"118","author":"Coello","year":"2024","journal-title":"Brain Behav Immun"},{"key":"2026062608320578000_16.5.e116196.6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/bdi.12245","article-title":"Elevated levels of urinary markers of oxidatively generated DNA and RNA damage in bipolar disorder","volume":"17","author":"Munkholm","year":"2015","journal-title":"Bipolar Disord"},{"key":"2026062608320578000_16.5.e116196.7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bbi.2022.12.011","article-title":"Persistent increase over time in oxidatively stress generated RNA and DNA damage in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives - An up to 5-year prospective study","volume":"108","author":"Coello","year":"2023","journal-title":"Brain Behav Immun"},{"key":"2026062608320578000_16.5.e116196.8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.freeradbiomed.2021.03.022","article-title":"Higher systemic oxidatively generated DNA and RNA damage in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives","volume":"168","author":"Coello","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"2026062608320578000_16.5.e116196.9","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12667"},{"key":"2026062608320578000_16.5.e116196.10","doi-asserted-by":"crossref","unstructured":"Kessing LV . Longitudinal course and clinical progression of bipolar disorder \u2013 an updated systematic review. In: Bipolar Disorder: An Evidence-Based Clinical Guide. 2025.","DOI":"10.1007\/978-3-031-85519-1_9"},{"key":"2026062608320578000_16.5.e116196.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2020.01.035"},{"key":"2026062608320578000_16.5.e116196.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2011.12.049"},{"key":"2026062608320578000_16.5.e116196.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2010.10.001"},{"key":"2026062608320578000_16.5.e116196.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2014.02.004"},{"key":"2026062608320578000_16.5.e116196.15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.9758\/cpn.2019.17.3.343","article-title":"Telomere Biology in Mood Disorders: An Updated, Comprehensive Review of the Literature","volume":"17","author":"Muneer","year":"2019","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"2026062608320578000_16.5.e116196.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijdevneu.2010.08.007"},{"key":"2026062608320578000_16.5.e116196.17","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyx001"},{"key":"2026062608320578000_16.5.e116196.18","unstructured":"APA . Diagnostic and statistical manual of mental disorders. 4th edn. American Psychiatric Association, 1994."},{"key":"2026062608320578000_16.5.e116196.19","doi-asserted-by":"crossref","unstructured":"APA . Diagnostic and statistical manual of mental disorders. 5th ed. American Psychiatric Association, 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"2026062608320578000_16.5.e116196.20","unstructured":"ICD-11, Available: https:\/\/icd.who.int\/browse11\/l-m\/en"},{"key":"2026062608320578000_16.5.e116196.21","doi-asserted-by":"publisher","DOI":"10.1177\/070674371506000310"},{"key":"2026062608320578000_16.5.e116196.22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jad.2016.10.031","article-title":"Differences in clinical presentation between bipolar I and II disorders in the early stages of bipolar disorder: A naturalistic study","volume":"208","author":"Vinberg","year":"2017","journal-title":"J Affect Disord"},{"key":"2026062608320578000_16.5.e116196.23","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.3.261"},{"key":"2026062608320578000_16.5.e116196.24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41398-020-01146-0","article-title":"Clinical and genetic differences between bipolar disorder type 1 and 2 in multiplex families","volume":"11","author":"Guzman-Parra","year":"2021","journal-title":"Transl Psychiatry"},{"key":"2026062608320578000_16.5.e116196.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2015.06.026"},{"key":"2026062608320578000_16.5.e116196.26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40345-019-0141-4","article-title":"Differences in mood instability in patients with bipolar disorder type I and II: a smartphone-based study","volume":"7","author":"Faurholt-Jepsen","year":"2019","journal-title":"Int J Bipolar Disord"},{"key":"2026062608320578000_16.5.e116196.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2010.08.030"},{"key":"2026062608320578000_16.5.e116196.28","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1176\/ajp.130.9.1006","article-title":"The Use of Lithium in Affective Disorders, III: A Double-Blind Study of Prophylaxis in Bipolar Illness","volume":"130","author":"Stallone","year":"1973","journal-title":"AJP"},{"key":"2026062608320578000_16.5.e116196.29","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.4.392"},{"key":"2026062608320578000_16.5.e116196.30","first-page":"215","article-title":"A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression","volume":"28","author":"Calabrese","year":"2001","journal-title":"Rev Psiquiatr Clin"},{"key":"2026062608320578000_16.5.e116196.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2009.01537.x"},{"key":"2026062608320578000_16.5.e116196.32","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.048504"},{"key":"2026062608320578000_16.5.e116196.33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2007.00500.x"},{"key":"2026062608320578000_16.5.e116196.34","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04152"},{"key":"2026062608320578000_16.5.e116196.35","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0906"},{"key":"2026062608320578000_16.5.e116196.36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/npr2.12056","article-title":"Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials with an enrichment design","volume":"39","author":"Oya","year":"2019","journal-title":"Neuropsychopharmacol Rep"},{"key":"2026062608320578000_16.5.e116196.37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S2215-0366(14)70314-1","article-title":"Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis","volume":"1","author":"Miura","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"2026062608320578000_16.5.e116196.38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jad.2020.03.030","article-title":"Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis","volume":"269","author":"Bahji","year":"2020","journal-title":"J Affect Disord"},{"key":"2026062608320578000_16.5.e116196.39","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181f15849"},{"key":"2026062608320578000_16.5.e116196.40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/WNF.0b013e3182055c07","article-title":"Safety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implications","volume":"34","author":"Seo","year":"2011","journal-title":"Clin Neuropharmacol"},{"key":"2026062608320578000_16.5.e116196.41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1399-5618.2005.00206.x","article-title":"Re-evaluation of randomized control trials of lithium monotherapy: a cohort effect","volume":"7","author":"Deshauer","year":"2005","journal-title":"Bipolar Disord"},{"key":"2026062608320578000_16.5.e116196.42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.161.2.217","article-title":"Long-Term Lithium Therapy for Bipolar Disorder: Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"161","author":"Geddes","year":"2004","journal-title":"AJP"},{"key":"2026062608320578000_16.5.e116196.43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1614.2005.01649.x"},{"key":"2026062608320578000_16.5.e116196.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2021.08.264"},{"key":"2026062608320578000_16.5.e116196.45","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1176\/ajp.155.5.638","article-title":"Lithium Maintenance Treatment of Depression and Mania in Bipolar I and Bipolar II Disorders","volume":"155","author":"Tondo","year":"1998","journal-title":"AJP"},{"key":"2026062608320578000_16.5.e116196.46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2007.00490.x"},{"key":"2026062608320578000_16.5.e116196.47","doi-asserted-by":"publisher","DOI":"10.1177\/0269881111414091"},{"key":"2026062608320578000_16.5.e116196.48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.biopsych.2006.12.031","article-title":"Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder","volume":"63","author":"Goldberg","year":"2008","journal-title":"Biol Psychiatry"},{"key":"2026062608320578000_16.5.e116196.49","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/acps.12717","article-title":"Is there consensus across international evidence\u2010based guidelines for the management of bipolar disorder?","volume":"135","author":"Parker","year":"2017","journal-title":"Acta Psychiatr Scand"},{"key":"2026062608320578000_16.5.e116196.50","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12609"},{"key":"2026062608320578000_16.5.e116196.51","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/acps.13070","article-title":"Lithium as the drug of choice for maintenance treatment in bipolar disorder","volume":"140","author":"Kessing","year":"2019","journal-title":"Acta Psychiatr Scand"},{"key":"2026062608320578000_16.5.e116196.52","doi-asserted-by":"crossref","unstructured":"Ulrichsen A , Hampsey E , Taylor RH , et al . Comparing measurements of lithium treatment efficacy in people with bipolar disorder: systematic review and meta-analysis. BJPsych open 2023;9. doi:10.1192\/bjo.2023.64","DOI":"10.1192\/bjo.2023.64"},{"key":"2026062608320578000_16.5.e116196.53","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jad.2025.04.125","article-title":"Lithium and lamotrigine for the treatment of bipolar II disorder - a systematic review and meta-analysis of randomized trials","volume":"383","author":"Fredskild","year":"2025","journal-title":"J Affect Disord"},{"key":"2026062608320578000_16.5.e116196.54","unstructured":"RADS . RfAaDS. Baggrundsnotat for medicinsk behandling af bipolar lidelse, 2015. Available: http:\/\/www.rads.dk\/media\/1904\/bipolar-depression-bgn-september-2015.pdf"},{"key":"2026062608320578000_16.5.e116196.55","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01334-4"},{"key":"2026062608320578000_16.5.e116196.56","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S2215-0366(23)00199-2","article-title":"Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis","volume":"10","author":"Yildiz","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"2026062608320578000_16.5.e116196.57","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40345-018-0133-9","article-title":"Antidepressants in bipolar depression: an enduring controversy","volume":"6","author":"Gitlin","year":"2018","journal-title":"Int J Bipolar Disord"},{"key":"2026062608320578000_16.5.e116196.58","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12595"},{"key":"2026062608320578000_16.5.e116196.59","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1007\/s12035-021-02719-w","article-title":"Lithium therapy subdues neuroinflammation to maintain pyramidal cells arborization and rescues neurobehavioural impairments in ovariectomized rats","volume":"59","author":"Rana","year":"2022","journal-title":"Mol Neurobiol"},{"key":"2026062608320578000_16.5.e116196.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2016.06.016"},{"key":"2026062608320578000_16.5.e116196.61","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.psyneuen.2018.01.024","article-title":"The relationship between inflammatory state and quantity of affective episodes in bipolar disorder","volume":"90","author":"Queissner","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"2026062608320578000_16.5.e116196.62","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/17460441.2019.1553951","article-title":"Lamotrigine as a mood stabilizer: insights from the pre-clinical evidence","volume":"14","author":"Miranda","year":"2019","journal-title":"Expert Opin Drug Discov"},{"key":"2026062608320578000_16.5.e116196.63","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/ijnp\/pyab080","article-title":"Effects of Lamotrigine and Topiramate on Glial Properties in an Astrocyte-Microglia Co-Culture Model of Inflammation","volume":"25","author":"Faustmann","year":"2022","journal-title":"Int J Neuropsychopharmacol"},{"key":"2026062608320578000_16.5.e116196.64","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jneuroim.2018.06.008","article-title":"Effect of lamotrigine on in vivo and in vitro cytokine secretion in murine model of inflammation","volume":"322","author":"Abu-Rish","year":"2018","journal-title":"J Neuroimmunol"},{"key":"2026062608320578000_16.5.e116196.65","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2026062608320578000_16.5.e116196.66","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.112.113548"},{"key":"2026062608320578000_16.5.e116196.67","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/acps.13716","article-title":"Early specialised treatment for bipolar disorder: Long-term follow-up from the early intervention in affective disorders (EIA) randomised controlled trial","volume":"150","author":"Munkholm","year":"2024","journal-title":"Acta Psychiatr Scand"},{"key":"2026062608320578000_16.5.e116196.68","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810180089012"},{"key":"2026062608320578000_16.5.e116196.69","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/08039488609096458","article-title":"UKU\u2019s Bivirkningsskala Skala Til Registering af U\u00f8nskede Virkninger af Psykofarmaka","volume":"40","author":"Bech","year":"1986","journal-title":"Nordisk Psykiatrisk Tidsskrift"},{"key":"2026062608320578000_16.5.e116196.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.03.049"},{"key":"2026062608320578000_16.5.e116196.71","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/bdi.12796","article-title":"Is smartphone-based mood instability associated with stress, quality of life, and functioning in bipolar disorder?","volume":"21","author":"Faurholt-Jepsen","year":"2019","journal-title":"Bipolar Disord"},{"key":"2026062608320578000_16.5.e116196.72","doi-asserted-by":"crossref","first-page":"17","DOI":"10.20344\/amp.348","article-title":"Medication adherence rating scale","volume":"24","author":"Vanelli","year":"2011","journal-title":"Acta Med Port"},{"key":"2026062608320578000_16.5.e116196.73","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1745-0179-2-8","article-title":"Attitudes and beliefs among patients treated with mood stabilizers","volume":"2","author":"Kessing","year":"2006","journal-title":"Clin Pract Epidemiol Ment Health"},{"key":"2026062608320578000_16.5.e116196.74","doi-asserted-by":"publisher","DOI":"10.1046\/j.0001-690X.2003.00193.x"},{"key":"2026062608320578000_16.5.e116196.75","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41398-019-0484-8","article-title":"Reporting guidelines on remotely collected electronic mood data in mood disorder (eMOOD)\u2014recommendations","volume":"9","author":"Faurholt-Jepsen","year":"2019","journal-title":"Transl Psychiatry"},{"key":"2026062608320578000_16.5.e116196.76","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.114.162073"},{"key":"2026062608320578000_16.5.e116196.77","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jad.2017.07.029","article-title":"Longitudinal mood monitoring in bipolar disorder: Course of illness as revealed through a short messaging service","volume":"223","author":"McKnight","year":"2017","journal-title":"J Affect Disord"},{"key":"2026062608320578000_16.5.e116196.78","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007504","article-title":"Mood instability is a common feature of mental health disorders and is associated with poor clinical outcomes","volume":"5","author":"Patel","year":"2015","journal-title":"BMJ Open"},{"key":"2026062608320578000_16.5.e116196.79","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12065"},{"key":"2026062608320578000_16.5.e116196.80","doi-asserted-by":"publisher","DOI":"10.1016\/J.JAD.2018.04.021"},{"key":"2026062608320578000_16.5.e116196.81","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.2011.1246"},{"key":"2026062608320578000_16.5.e116196.82","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.euroneuro.2022.02.005","article-title":"Mood instability \u2013 A new outcome measure in randomised trials of bipolar disorder?","volume":"58","author":"Kessing","year":"2022","journal-title":"Eur Neuropsychopharmacol"},{"key":"2026062608320578000_16.5.e116196.83","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.114.158543"},{"key":"2026062608320578000_16.5.e116196.84","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2010.00807.x"},{"key":"2026062608320578000_16.5.e116196.85","doi-asserted-by":"publisher","DOI":"10.1037\/a0017075"},{"key":"2026062608320578000_16.5.e116196.86","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.clinpsy.3.022806.091415"},{"key":"2026062608320578000_16.5.e116196.87","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291715000410"},{"key":"2026062608320578000_16.5.e116196.88","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291719000710"},{"key":"2026062608320578000_16.5.e116196.89","doi-asserted-by":"publisher","DOI":"10.1037\/a0014173"},{"key":"2026062608320578000_16.5.e116196.90","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jad.2014.10.047","article-title":"Fewer study participants needed to demonstrate superior antidepressant efficacy when using the Hamilton melancholia subscale (HAM-D 6) as outcome measure","volume":"190","author":"\u00d8stergaard","year":"2016","journal-title":"J Affect Disord"},{"key":"2026062608320578000_16.5.e116196.91","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.23.1.56"},{"key":"2026062608320578000_16.5.e116196.92","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.133.5.429"},{"key":"2026062608320578000_16.5.e116196.93","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jad.2013.02.022","article-title":"Validity and reliability of a rating scale on subjective cognitive deficits in bipolar disorder (COBRA)","volume":"150","author":"Rosa","year":"2013","journal-title":"J Affect Disord"},{"key":"2026062608320578000_16.5.e116196.94","doi-asserted-by":"publisher","DOI":"10.1186\/1745-0179-3-5"},{"key":"2026062608320578000_16.5.e116196.95","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291798006667"},{"key":"2026062608320578000_16.5.e116196.96","doi-asserted-by":"publisher","DOI":"10.2307\/2136404"},{"key":"2026062608320578000_16.5.e116196.97","doi-asserted-by":"publisher","DOI":"10.1249\/01.MSS.0000078924.61453.FB"},{"key":"2026062608320578000_16.5.e116196.98","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(89)90047-4"},{"key":"2026062608320578000_16.5.e116196.99","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.8.1132"},{"key":"2026062608320578000_16.5.e116196.100","first-page":"731","article-title":"The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity","volume":"33","author":"Clayton","year":"1997","journal-title":"Psychopharmacol Bull"},{"key":"2026062608320578000_16.5.e116196.101","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2014.03.009"},{"key":"2026062608320578000_16.5.e116196.102","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015462","article-title":"The Bipolar Illness Onset study: research protocol for the BIO cohort study","volume":"7","author":"Kessing","year":"2017","journal-title":"BMJ Open"},{"key":"2026062608320578000_16.5.e116196.103","unstructured":"Medicin.dk, Available: https:\/\/pro.medicin.dk"},{"key":"2026062608320578000_16.5.e116196.104","unstructured":"Danish Medicines Agency, Summary of Product Characteristics, Available: https:\/\/produktresume.dk\/AppBuilder\/search"},{"key":"2026062608320578000_16.5.e116196.105","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/acps.70055","article-title":"No Effect of Low-Dose Aspirin Versus Placebo as Add-On Treatment in Bipolar Disorder-Results From a Randomised Controlled Trial (the A-Bipolar RCT)","volume":"153","author":"Bruun","year":"2026","journal-title":"Acta Psychiatr Scand"},{"key":"2026062608320578000_16.5.e116196.106","unstructured":"RStudio Team . RStudio: Integrated Development Environment for R (Version 2024.04.2) [Computer software]. Posit Software, PBC. Available: https:\/\/posit.co"},{"key":"2026062608320578000_16.5.e116196.107","doi-asserted-by":"publisher","DOI":"10.1177\/0748730414553029"},{"key":"2026062608320578000_16.5.e116196.108","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-084105","article-title":"Effects of low-dose aspirin in bipolar disorder: study protocol for a randomised controlled trial (the A-Bipolar RCT)","volume":"14","author":"Bruun","year":"2024","journal-title":"BMJ Open"},{"key":"2026062608320578000_16.5.e116196.109","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m12834","article-title":"Adding Increased Energy or Activity to Criterion (A) of the DSM-5 Definition of Hypomania and Mania: Effect on the Diagnoses of 907 Patients From the Bipolar Collaborative Network","volume":"80","author":"Fredskild","year":"2019","journal-title":"J Clin Psychiatry"},{"key":"2026062608320578000_16.5.e116196.110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40345-020-00219-9","article-title":"Impact of modification to DSM-5 criterion A for hypomania\/mania in newly diagnosed bipolar patients: findings from the prospective BIO study","volume":"9","author":"Fredskild","year":"2021","journal-title":"Int J Bipolar Disord"},{"key":"2026062608320578000_16.5.e116196.111","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"8","author":"Schulz","year":"2010","journal-title":"BMC Med"},{"key":"2026062608320578000_16.5.e116196.112","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-116196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:43:51Z","timestamp":1782488631000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-116196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":112,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,8]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/bmjopen-2026-116196"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-116196","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}